The American Journal of Medicine
Volume 119, Issue 5, Supplement 1 , Pages S17-S23 , May 2006

The Obese Patient with Diabetes Mellitus: From Research Targets to Treatment Options

  • Arya M. Sharma, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Arya M. Sharma, MD, PhD, Department of Medicine, McMaster University, Hamilton General Hospital, 237 Barton Street East, Ontario L8L 2X2, Canada.

References 

  1. Deitel M . Overweight and obesity worldwide now estimated to involve 1.7 billion people . Obes Surg . 2003;13:329–330
  2. Chan JM , Stampfer MJ , Rimm EB , Willett WC , Colditz GA . Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men . Diabetes Care . 1994;17:961–969
  3. Colditz GA , Willet WC , Rotnitzky A , Manson JE . Weight gain as a risk factor for clinical diabetes mellitus in women . Ann Intern Med . 1995;122:481–486
  4. Kissebah AH , Vydelingum N , Murray R , et al.   Relation of body fat distribution to metabolic complications of obesity . J Clin Endocrinol Metab . 1982;54:254–260
  5. Iacobellis G , Corradi D , Sharma AM . Epicardial adipose tissue (anatomic, biomolecular, and clinical relationships with the heart) . Nat Clin Pract Cardiovasc Med . 2005;2:536–543
  6. Yusuf S , Hawken S , Ôunpuu S , et al.   Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) (case-control study) . Lancet . 2004;364:937–952
  7. Yusuf S , Hawken S , Ôunpuu S , et al.   Obesity and the risk of myocardial infarction (a case-control study in 27,000 subjects from 52 countries) . Lancet . 2005;366:1640–1649
  8. lberti KG , Zimmet PZ . Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1 (Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation) . Diabet Med . 1998;15:539–553
  9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report . Circulation . 2002;106:3143–3421
  10. Sharma AM . Adipose tissue (a mediator of cardiovascular risk) . Int J Obes Relat Metab Disord . 2002;26(suppl 4):S5–S7
  11. Abate N , Garg A , Peshock RM , et al.   Relationships of generalized and regional adiposity to insulin sensitivity in men . J Clin Invest . 1995;96:88–98
  12. Klein S , Fontana L , Young VL , et al.   Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease . N Engl J Med . 2004;350:2549–2557
  13. Buchwald H , Avidor Y , Braunwald E , et al.   Bariatric surgery (a systematic review and meta-analysis) . JAMA . 2004;292:1724–1737
  14. Diabetes Prevention Program Research Group . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin . N Engl J Med . 2002;346:393–403
  15. Pan XR , Li GW , Hu YH , et al.   Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance (the Da Qing IGT and Diabetes Study) . Diabetes Care . 1997;20:537–544
  16. Tuomilehto J , Lindstrom J , Eriksson JG , et al.   Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance . N Engl J Med . 2001;344:1343–1350
  17. Lean MEJ , Powrie JK , Anderson AS , et al.   Obesity, weight loss, and prognosis in type 2 diabetes . Diabet Med . 1990;7:228–233
  18. UK Prospective Diabetes Study Group . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) . Lancet . 1998;352:854–865
  19. UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) . [published correction appears in Lancet. 1999;354:60] Lancet . 1998;352:837–853
  20. Scheen AJ . VALUE (analysis of results) . [letter] Lancet . 2004;362:932–933
  21. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group . Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker or diuretic (the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)) . JAMA . 2002;288:2981–2997
  22. Hansson L , Lindholm LH , Niskanen L , et al.   Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension (the Captopril Prevention Project (CAPPP) randomised trial) . Lancet . 1999;353:611–616
  23. The Heart Outcomes Prevention Evaluation Study Investigators . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients . N Engl J Med . 2000;342:145–153
  24. Dahlöf B , Devereux RB , Kjeldsen SE , et al.   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) (a randomised trial against atenolol) . Lancet . 2002;359:995–1003
  25. Lithell H , Hansson L , Skoog I , et al.   The Study on Cognition and Prognosis in the Elderly (SCOPE) (principal results of a randomized double-blind intervention trial) . J Hypertens . 2003;21:875–886
  26. Hansson L , Lindholm L , Ekbom T , et al.   Randomised trial of old and new antihypertensive drugs in elderly patients (cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 Study) . Lancet . 1999;354:1751–1756
  27. Julius S , Kjeldsen SE , Weber M , et al.   Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine (the VALUE randomised trial) . Lancet . 2004;363:2022–2031
  28. Engeli S , Böhnke J , Gorzelniak K , et al.   Weight loss and the renin-angiotensin-aldosterone system . Hypertension . 2005;45:356–362
  29. Ahima RS , Flier JS . Adipose tissue as an endocrine organ . Trends Endocrinol Metab . 2000;11:327–332
  30. Nisoli E , Clementi E , Tonello C , et al.   Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures . Br J Pharmacol . 1998;125:888–894
  31. Aubert J , Saint-Marc P , Belmonte N , Dani C , Negrel R , Ailhaud J . Prostacyclin IP receptor up-regulates the early expression of C/EBP-beta and C/EBP-delta in preadipose cells . Mol Cell Endocrinol . 2000;160:149–156
  32. Hauner H , Petruschke T , Gries FA . Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells . Metabolism . 1994;43:227–232
  33. Ailhaud G , Fukamizu A , Massiera F , et al.   Angiotensinogen, angiotensin II, and adipose tissue development . Int J Obes Relat Metab Disord . 2000;24(suppl 4):S33–S35
  34. Janke J , Engeli S , Gorzelniak K , Luft FC , Sharma AM . Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors . Diabetes . 2002;51:1699–1707
  35. Sharma AM , Janke J , Gorzelniak K , et al.   Angiotensin blockade prevents type 2 diabetes by formation of fat cells . Hypertension . 2002;40:609–611
  36. Gavrilova O , Mareus-Samuels B , Graham D , et al.   Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice . J Clin Invest . 2000;105:271–278
  37. McGarry JD , Dobbins RL . Fatty acids, lipotoxicity, and insulin secretion . Diabetologia . 1999;42:128–138
  38. Weber M . The telmisartan Programme of Research tO show Telmisartan End-organ proteCTION (PROTECTION) Programme . J Hypertens . 2003;21(suppl 6):S37–S46
  39. Sharma AM. Study of Micardis on overweight/obese type 2 diabetics with hypertension (SMOOTH): rationale and design. Presented at the 7th International Forum for the Evaluation of Cardiovascular Care; January 2004; Monte Carlo, Monaco.

PII: S0002-9343(06)00101-X

doi: 10.1016/j.amjmed.2006.01.010

The American Journal of Medicine
Volume 119, Issue 5, Supplement 1 , Pages S17-S23 , May 2006

Article Tools

* Image Usage & Resolution